RAFAEL HOLDINGS, INC. Increase (Decrease) in Other Operating Liabilities
RAFAEL HOLDINGS, INC. (RFL) reported Increase (Decrease) in Other Operating Liabilities of $104.00 thousand for the 12-month period ending 2019-07-31, per its 10-K filed 2019-10-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2019-10-04
- RAFAEL HOLDINGS, INC. increase (decrease) in other operating liabilities for the quarter ending 2019-07-31 was $82.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in other operating liabilities for the quarter ending 2019-04-30 was $37.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in other operating liabilities for the quarter ending 2019-01-31 was -$1.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in other operating liabilities for the quarter ending 2018-10-31 was -$14.00K.
- RAFAEL HOLDINGS, INC. increase (decrease) in other operating liabilities for fiscal 2019 was $104.00K, a 11.86% decline from fiscal 2018.
- RAFAEL HOLDINGS, INC. increase (decrease) in other operating liabilities for fiscal 2018 was $118.00K, a 461.90% increase from fiscal 2017.
- RAFAEL HOLDINGS, INC. increase (decrease) in other operating liabilities for fiscal 2017 was $21.00K, a 22.22% decline from fiscal 2016.
- RAFAEL HOLDINGS, INC. increase (decrease) in other operating liabilities for fiscal 2016 was $27.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2019-07-31 | $82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-04 | $119.00K derived: sum of 2 quarters · filed 2019-10-04 | $118.00K derived: sum of 3 quarters · filed 2019-10-04 | $104.00K 10-K · filed 2019-10-04 |
| 2019-04-30 | $37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-06-05 | $36.00K derived: sum of 2 quarters · filed 2019-06-05 | $22.00K 10-Q · filed 2019-06-05 | |
| 2019-01-31 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-03-12 | -$15.00K 10-Q · filed 2019-03-12 | ||
| 2018-10-31 | -$14.00K 10-Q · filed 2018-12-10 | |||
| 2018-07-31 | $118.00K 10-K · filed 2019-10-04 | |||
| 2018-01-31 | $25.00K 10-Q · filed 2019-03-12 | |||
| 2017-07-31 | -$157.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-15 | $6.00K derived: sum of 2 quarters · filed 2018-10-15 | $21.00K 10-K · filed 2018-10-15 | |
| 2017-04-30 | $163.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-06-11 | $178.00K 10-Q · filed 2018-06-11 | ||
| 2017-01-31 | $15.00K 10-Q · filed 2018-03-12 | |||
| 2016-07-31 | $27.00K 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |